235 related articles for article (PubMed ID: 2163054)
1. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors.
Zhang XK; Huang DP; Qiu DK; Chiu JF
Oncogene; 1990 Jun; 5(6):909-14. PubMed ID: 2163054
[TBL] [Abstract][Full Text] [Related]
2. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.
Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G
Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926
[TBL] [Abstract][Full Text] [Related]
3. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G
Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435
[TBL] [Abstract][Full Text] [Related]
4. ras oncogene p21 expression in hepatocellular carcinoma.
Jagirdar J; Nonomura A; Patil J; Thor A; Paronetto F
J Exp Pathol; 1989; 4(1):37-46. PubMed ID: 2550600
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of expression of p21 and c-myc protein in hepatocellular carcinoma with pericarcinomatous liver tissue].
Feng D; Cheng R; Yan Y
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):310-2. PubMed ID: 9868083
[TBL] [Abstract][Full Text] [Related]
6. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
Chan KL; Guan XY; Ng IO
Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
[TBL] [Abstract][Full Text] [Related]
7. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
8. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells.
Olah E; Kote Z; Natsumeda Y; Yamaji Y; Jarai G; Lapis E; Financsek I; Weber G
Cancer Biochem Biophys; 1990 Apr; 11(2):107-17. PubMed ID: 1974479
[TBL] [Abstract][Full Text] [Related]
10. [Expression of cellular oncogenes in human hepatocellular carcinoma cell line BEL 7402 and the effect of sodium butyrate on the expression of cellular oncogenes].
Li SY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun; 12(3):227-30. PubMed ID: 1964112
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between hypomethylation of c-myc and c-N-ras oncogenes and pathological changes in human hepatocellular carcinoma].
Shen L; Qui D; Fang J
Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):173-6. PubMed ID: 10920889
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
14. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.
Richards CA; Short SA; Thorgeirsson SS; Huber BE
Cancer Res; 1990 Mar; 50(5):1521-7. PubMed ID: 2154325
[TBL] [Abstract][Full Text] [Related]
16. Oncogene-induced liver neoplasia in transgenic mice.
Sandgren EP; Quaife CJ; Pinkert CA; Palmiter RD; Brinster RL
Oncogene; 1989 Jun; 4(6):715-24. PubMed ID: 2543942
[TBL] [Abstract][Full Text] [Related]
17. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
Shiraishi M; Noguchi M; Shimosato Y; Sekiya T
Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical localization of p21 ras gene product in human hepatoma cell lines and corresponding tumors in athymic mice.
Matarazzo M; Faraggiana T; Donato MF; Paronetto F
J Exp Pathol; 1987; 3(3):305-15. PubMed ID: 2835467
[TBL] [Abstract][Full Text] [Related]
20. [Expression of ras oncogene p21 product and proliferating cell nuclear antigen in liver cirrhosis and the correlation with liver cell dysplasia].
Feng Z; He R; Lu Z; Ling Y
Zhonghua Gan Zang Bing Za Zhi; 2000 Dec; 8(6):343-5. PubMed ID: 11135691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]